FIELD: medicine, ophthalmology. SUBSTANCE: agent is biosoluble polymer with hydrophilic plasticizing addition and has emoxipin and pyridoxine hydrochloride at corresponding quantitative ratio of components. Agent shows local prolonged action and presents noninvasive agent for treatment of progressive and complicated myopia, open-angle glaucoma, diabetic retinopathy, intraocular hemorrhage of different etiology. EFFECT: enhanced effectiveness of treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CARRYING OUT MEDICAL TREATMENT OF PROGRESSIVE AND COMPLICATED MYOPIA | 2000 |
|
RU2192261C2 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR EARLY ACQUIRED AND CONGENITAL PROGRESSIVE MYOPIA | 2012 |
|
RU2495420C1 |
| MEDICATION FOR PREVENTION AND TREATMENT OF OPHTHALMOLOGICAL DISEASES | 2008 |
|
RU2359658C1 |
| DIAGNOSTIC TECHNIQUE FOR SCLERAL SUPPORT MALFUNCTION, ACCOMPANYING MYOPIA IN CHILDREN AND ADOLESCENTS | 2013 |
|
RU2541756C2 |
| METHOD FOR PREDICTING PROGRESSING MYOPIA DEVELOPMENT IN CHILDREN | 1997 |
|
RU2133036C1 |
| MEDICINAL OPHTHALMIC FILM AND METHOD FOR ITS PRODUCING | 1992 |
|
RU2056819C1 |
| METHOD FOR TREATING THE CASES OF PROGRESSIVE AND AGGRAVATED MYOPIA | 2003 |
|
RU2238704C1 |
| COMPOSITION FOR TREATING PROGRESSIVE MYOPIA | 1987 |
|
RU2012336C1 |
| METHOD FOR PRODUCING BIOSOLUBLE COPOLYMERS OF ACRYLAMIDE, VINYLPYRROLIDONE AND ALKYLACRYLATE | 2007 |
|
RU2352589C1 |
| METHOD FOR TREATING THE CASES OF PROGRESSIVE MYOPIA | 0 |
|
SU1680161A1 |
